Vimarsana
Biggest News Aggregation in the World

Page 21 - Genome Editing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genome Editing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genome Editing Today - Breaking & Trending Today

LABVOLUTION 2023: Paving the way for the lab of the future - Vimarsana News

LABVOLUTION 2023: Paving the way for the lab of the future

Decision-makers, product developers and users from the various segments of the laboratory industry gather in Hannover, Germany from 09 to 11 May 2023 to get a close look at the latest developments and future trends at LABVOLUTION. Click to read more...

Reducing the mutation problem in gene therapy - Vimarsana News

Reducing the mutation problem in gene therapy

Researchers have developed an optimised genome-editing method that reduces mutations, opening the door to more effective treatment of genetic diseases.

Precise genome editing approach can correct mutation that causes sickle cell disease - Vimarsana News

Precise genome editing approach can correct mutation that causes sickle cell disease

Scientists at St. Jude Children’s Research Hospital and the Broad Institute of MIT and Harvard showed how prime editing can correct the mutation that causes sickle cell disease in a potentially curative approach.

Forget designer babies. Here's how CRISPR is really changing lives - Vimarsana News

Forget designer babies. Here's how CRISPR is really changing lives

Forget about He Jiankui, the Chinese scientist who created gene-edited babies. Instead, when you think about gene editing you should think of Victoria Gray, the African-American woman who says she’s been cured of her sickle-cell disease symptoms.  This week in London, scientists are gathering for the Third International Summit on Human Genome Editing. It’s gene…

Pillar Biosciences and KeyGene Enter into Licensing Agreement - Vimarsana News

Pillar Biosciences and KeyGene Enter into Licensing Agreement

/PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine™, which develops and distributes next-generation sequencing (NGS) tests to localize...